Company Filing History:
Years Active: 2000-2016
Title: The Innovative Journey of Inventor Kevin J Brodbeck
Introduction: Kevin J Brodbeck, based in Palo Alto, California, is an esteemed inventor known for his impactful contributions in the field of biopharmaceutical therapy. With a portfolio of seven patents, Brodbeck has gained recognition for developing innovative solutions that enhance therapeutic agent delivery, promising significant advancements in medical treatments.
Latest Patents: Among his latest patents, one notable invention is titled "Pastes for Injection of a Therapeutic Agent." This patent discloses a paste designed for the injection of therapeutic agents, comprising a powder effectively contained within a pharmaceutically acceptable carrier. The paste facilitates an injection volume ranging from 0.1 to 3000 microliters.
Another recent patent, "Intracutaneous Paste Composition," addresses the delivery of biopharmaceutical and other therapeutic agents through minimally invasive, low-pain administration. This invention promotes the delivery of therapeutic agents to patients via the epidermal, dermal, or subcutaneous layers of the skin, utilizing a concentrated injectable paste or slurry.
Career Highlights: Kevin's illustrious career includes significant roles at renowned companies such as Alza Corporation and Xeris Pharmaceuticals, Inc. His experiences within these organizations have furthered his expertise and contributed to his innovative mindset and patent-driven achievements in the pharmaceutical industry.
Collaborations: Throughout his career, Brodbeck has collaborated with notable professionals in the field, including Theodore Tao-Ian Shen and Ann T Gaynor-Duarte. These partnerships have allowed him to expand his knowledge and enhance the quality of his inventions.
Conclusion: Kevin J Brodbeck's contributions to the field of biopharmaceuticals through innovative patents underscore his dedication to advancing therapeutic delivery systems. His work continues to impact the medical industry positively, paving the way for more effective and less invasive treatment options for patients.